Introduction
A coronal T2-weighted MR image showing altered signals in temporal lobes consistent with encephalitis in a patient positive for HSV type 1.
[1].
By J. Sebastián Chávez Erazo[]
Viral Description
Include some current research, with at least one figure showing data.
Every point of information REQUIRES CITATION using the citation tool shown above.
HSV Vaccine
Include some current research, with at least one figure showing data.
Herpes and Alzheimer's/Encephalitis
Include some current research, with at least one figure showing data.
References
[1] "Chentoufi, A. A., et al. “Toward a rational design of an asymptomatic clinical Herpes vaccine: the old, the new, and the unknown,” Clinical and Developmental Immunology. Article ID 187585, 16 pages, 2012. ".
[2] "Diaz, M. F., Knipe, D. M., “Protections from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus,” Virology 488, 61-67, 2015.".
[3] "Lövheim, H., et. al. “Reactivated herpes simplex infection increases the risk of Alzheimer’s disease,” Alzheimer’s and Dementia 11, 593-599, 2015.".
[4] "Ball, M. J., et. al. “Intracerebral propagation of Alzheimer’s disease: strengthening evidence of a herpes simplex virus etiology,” Alzheimer’s and Dementia, 9, 169-175, 2013. ".
[5] "Dikici, S., et. al. “Postpartum herpes encephalitis that apply with status epilepticus: case report,” Am J Clin Obstet Gynecol 2(4):185-188, 2015. ".
[6] "Kakiuchi, S., et. al. “Neonatal herpes encephalitis caused by a virologically confirmed acyclovir-resistant herpes simplex virus 1 strain,” Journal of Clinical Microbiology, Volume 51, 356-359, 2013.".
[7] "Turriziani, O., et. al. “Early collection of saliva specimens from Bell’s Palsy patients: quantitative analysis of HHV-6, HSV-1, and VZV,” Journal of Medical Virology, 86:1752-1758, 2014. ".
[8] "Greco, A., Gallo, A., Marinelli, C., Macri, G.F., and de Vincentiis, M. “Bell’s palsy and autoimmunity,” Elsevier Autoimmunity Reviews 12:323-328, 2012.".
[9] "Leroux-Roels, G., et. al. “Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults, a double-blind randomized trial,” Human Vaccines and Immunotherapeutics 9:6, 1254-1262, 2013.".
[10] "Vogel, K., Thomann, S., Vogel, B., Shuster, P., and Schmidt, B. “Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections,” Immunology, 143, 588-600, 2014. ".
[11] "Awasthi, S., and Friedman, H. M. “A paradigm shift: vaccine-induced antibodies as an immune correlate of protection against herpes simplex virus type 1 genital herpes,” The Journal of Infectious Diseases 209, 813-815, 2014.".
[12] . "Centers for Disease Control and Prevention: Genital Herpes. ".
[13] "Slonczewski, J. L., Foster, J. W. “Microbiology an evolving science,” New York, W.W. Norton & Company, Inc., 2014.".
Authored for BIOL 238 Microbiology, taught by Joan Slonczewski, 2016, Kenyon College.
